Remdesivir
-
COVID-19: US and Japan Start Gilead's Remdesivir Treatment
The treatment of Gilead Sciences Inc. for patients severely ill with COVID-19 in Japan has begun days after granting emergency approval to the medication.
Latest Research Articles
most popular
-
Beyond the Aurora: How Do Solar Flares Affect Electronics
-
WhaleX Team Creates Synthetic Whale Poop to Revive Ocean Ecosystems
-
Catastrophic Wildfire in New York Kills 18-Year-Old Park Employee, Triggers Unhealthy Air Readings
-
Antarctica’s 'Doomsday Glacier' May Get Protection Barrier in Effort to Prevent Flooding
-
Microplastics Could Form Clouds and Severely Affect Weather, Climate
